{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:53:08Z","timestamp":1781736788993,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"DOI":"10.1186\/s13023-026-04361-y","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:14:05Z","timestamp":1777050845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurological management and outcome measures in Fabry disease: consensus statements from the Italian Fabry disease neurological working group"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2738-8562","authenticated-orcid":false,"given":"Michelangelo","family":"Mancuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Ulivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirio","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bersano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Cosottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Manara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pichiecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Siniscalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Tenuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Tuttolomondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"4","key":"4361_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/cge.14102","volume":"101","author":"DP Germain","year":"2022","unstructured":"Germain DP, Levade T, Hachulla E, Knebelmann B, Lacombe D, Seguin VL, et al. Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease. Clin Genet. 2022;101(4):390\u2013402. https:\/\/doi.org\/10.1111\/cge.14102.","journal-title":"Clin Genet"},{"key":"4361_CR2","doi-asserted-by":"publisher","unstructured":"Burlina AP, Politei J. Fabry Disease. In: Burlina AP, editor. Neurometabolic hereditary diseases of adults [Internet]. Cham: Springer International Publishing; 2018 [cited 2025 Sep 12]. p. 67\u201398. Available from: https:\/\/doi.org\/10.1007\/978-3-319-76148-0_4","DOI":"10.1007\/978-3-319-76148-0_4"},{"issue":"6","key":"4361_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/ene.14183","volume":"27","author":"M Mancuso","year":"2020","unstructured":"Mancuso M, Arnold M, Bersano A, Burlina A, Chabriat H, Debette S, et al. Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol. 2020;27(6):909\u201327. https:\/\/doi.org\/10.1111\/ene.14183. PubMed PMID: 32196841.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4361_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/ijms25010061","volume":"25","author":"A Tuttolomondo","year":"2024","unstructured":"Tuttolomondo A, Baglio I, Riolo R, Todaro F, Parrinello G, Miceli S, et al. Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson\u2013Fabry Disease. Int J Mol Sci. 2024;25(1):61. https:\/\/doi.org\/10.3390\/ijms25010061.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4361_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","volume":"46","author":"E Kolodny","year":"2015","unstructured":"Kolodny E, Fellgiebel A, Hilz MJ, Sims K, Caruso P, Phan TG, et al. Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke. 2015;46(1):302\u201313. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006283. PubMed PMID: 25492902.","journal-title":"Stroke"},{"issue":"8","key":"4361_CR6","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1007\/s00415-020-09836-x","volume":"268","author":"A Bersano","year":"2021","unstructured":"Bersano A, Kraemer M, Burlina A, Mancuso M, Finsterer J, Sacco S, et al. Heritable and non-heritable uncommon causes of stroke. J Neurol. 2021;268(8):2780\u2013807. https:\/\/doi.org\/10.1007\/s00415-020-09836-x.","journal-title":"J Neurol"},{"key":"4361_CR7","doi-asserted-by":"publisher","unstructured":"Burlina AP. Fabry Disease. In: Sharma P, Meschia JF, editors. Stroke genetics [Internet]. Cham: Springer International Publishing; 2024 [cited 2025 Sep 12]. pp. 89\u2013116. Available from: https:\/\/doi.org\/10.1007\/978-3-031-41777-1_5.","DOI":"10.1007\/978-3-031-41777-1_5"},{"issue":"7","key":"4361_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/cns.12542","volume":"22","author":"JM Politei","year":"2016","unstructured":"Politei JM, Bouhassira D, Germain DP, Goizet C, Guerrero-Sola A, Hilz MJ, et al. Pain in Fabry disease: practical recommendations for diagnosis and treatment. CNS Neurosci Ther. 2016;22(7):568\u201376. https:\/\/doi.org\/10.1111\/cns.12542. PubMed PMID: 27297686; PubMed Central PMCID: PMC5071655.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"4361_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13023-024-03500-7","volume":"20","author":"E Brand","year":"2025","unstructured":"Brand E, Linhart A, Deegan P, Jurcut R, Pisani A, Torra R, et al. Clinical management of female patients with Fabry disease based on expert consensus. Orphanet J Rare Dis. 2025;20(1):7. https:\/\/doi.org\/10.1186\/s13023-024-03500-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4361_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.6515\/ACS.202409_40(5)","volume":"40","author":"CL Hung","year":"2024","unstructured":"Hung CL, Wu YW, Kuo L, Sung KT, Lin HH, Chang WT, et al. 2024 Update of the TSOC Expert Consensus of Fabry Disease. Acta Cardiol Sin. 2024;40(5):544\u201368. https:\/\/doi.org\/10.6515\/ACS.202409_40(5). 20240731A PubMed PMID: 39308653; PubMed Central PMCID: PMC11413953.","journal-title":"Acta Cardiol Sin"},{"key":"4361_CR11","doi-asserted-by":"publisher","unstructured":"Germain DP, Altarescu G, Barriales-Villa R, Mignani R, Pawlaczyk K, Pieruzzi F, et al. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease. Mol Genet Metab. 2022;137(1):49\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2022.07.010.","DOI":"10.1016\/j.ymgme.2022.07.010"},{"key":"4361_CR12","doi-asserted-by":"publisher","unstructured":"Aleksovska K, Kobulashvili T, Costa J, Zimmermann G, Ritchie K, Reinhard C, et al. European academy of neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases. Eur J Neurol. 2022. https:\/\/doi.org\/10.1111\/ENE.15267. PubMed PMID: 35318776.","DOI":"10.1111\/ENE.15267"},{"issue":"1","key":"4361_CR13","doi-asserted-by":"publisher","first-page":"e1004326","DOI":"10.1371\/journal.pmed.1004326","volume":"21","author":"WT Gattrell","year":"2024","unstructured":"Gattrell WT, Logullo P, van Zuuren EJ, Price A, Hughes EL, Blazey P, et al. ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLOS Med. 2024;21(1):e1004326. https:\/\/doi.org\/10.1371\/journal.pmed.1004326.","journal-title":"PLOS Med"},{"key":"4361_CR14","doi-asserted-by":"crossref","unstructured":"Genetic Factors of Cerebral Small Vessel Disease and Their. Potential Clinical Outcome [Internet]. [cited 2025 Jul 28]. Available from: https:\/\/www.mdpi.com\/1422-0067\/20\/17\/4298?utm_source=chatgpt.com","DOI":"10.3390\/ijms20174298"},{"issue":"8","key":"4361_CR15","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/WNL.59","volume":"59","author":"HS Markus","year":"2002","unstructured":"Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, et al. Diagnostic strategies in CADASIL. Neurology. 2002;59(8):1134\u20138. https:\/\/doi.org\/10.1212\/WNL.59.8.1134 PubMed PMID: 12395806.","journal-title":"Neurology"},{"issue":"10","key":"4361_CR16","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1007\/s12325-019-01061-x","volume":"36","author":"O Morand","year":"2019","unstructured":"Morand O, Johnson J, Walter J, Atkinson L, Kline G, Frey A, et al. Symptoms and quality of life in patients with Fabry disease: results from an international patient survey. Adv Ther. 2019;36(10):2866\u201380. https:\/\/doi.org\/10.1007\/s12325-019-01061-x.","journal-title":"Adv Ther"},{"issue":"1","key":"4361_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-024-03090-4","volume":"19","author":"L Berry","year":"2024","unstructured":"Berry L, Walter J, Johnson J, Alton J, Powers J, Ll\u00f2ria X, et al. Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents. Orphanet J Rare Dis. 2024;19(1):153. https:\/\/doi.org\/10.1186\/s13023-024-03090-4.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"4361_CR18","doi-asserted-by":"publisher","first-page":"e0180581","DOI":"10.1371\/journal.pone.0180581","volume":"12","author":"R Liguori","year":"2017","unstructured":"Liguori R, Incensi A, de Pasqua S, Mignani R, Fileccia E, Santostefano M, et al. Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy. PLoS ONE. 2017;12(7):e0180581. https:\/\/doi.org\/10.1371\/journal.pone.0180581.","journal-title":"PLoS ONE"},{"key":"4361_CR19","doi-asserted-by":"publisher","unstructured":"Quantitative sensory testing. a comprehensive protocol for clinical trials - Rolke\u2009\u2013\u20092006 - European Journal of Pain - Wiley Online Library [Internet]. [cited 2025 Sep 12]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1016\/j.ejpain.2005.02.003","DOI":"10.1016\/j.ejpain.2005.02.003"},{"issue":"11","key":"4361_CR20","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.clinph.2005.07.009","volume":"116","author":"V Donadio","year":"2005","unstructured":"Donadio V, Lenzi P, Montagna P, Falzone F, Baruzzi A, Liguori R. Habituation of sympathetic sudomotor and vasomotor skin responses: neural and non-neural components in healthy subjects. Clin Neurophysiol. 2005;116(11):2542\u20139. https:\/\/doi.org\/10.1016\/j.clinph.2005.07.009.","journal-title":"Clin Neurophysiol"},{"key":"4361_CR21","doi-asserted-by":"publisher","first-page":"117863292412299","DOI":"10.1177\/11786329241229917","volume":"17","author":"K Jarvis","year":"2024","unstructured":"Jarvis K, Thetford C, Turck E, Ogley K, Stockley RC. Understanding the Barriers and Facilitators of Digital Health Technology (DHT) Implementation in Neurological Rehabilitation: An Integrative Systematic Review. Health Serv Insights. 2024;17:11786329241229917. https:\/\/doi.org\/10.1177\/11786329241229917.","journal-title":"Health Serv Insights"},{"issue":"12","key":"4361_CR22","doi-asserted-by":"publisher","first-page":"6167","DOI":"10.1007\/s10072-025-08428-9","volume":"46","author":"F Iodice","year":"2025","unstructured":"Iodice F, Cuffaro L, Romoli M, Bianchini E, Sparaco M, Arighi A, et al. A comprehensive guide to digital neurology. An update on current development on digital neurology derived from the Digital Neuro Hub project. Neurol Sci. 2025;46(12):6167\u201379. https:\/\/doi.org\/10.1007\/s10072-025-08428-9.","journal-title":"Neurol Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04361-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:44:26Z","timestamp":1781736266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4361"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04361-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require research ethics committee approval because it is a consensus study based on expert opinion and does not involve human subjects, patient recruitment, or the use of identifiable personal or clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MM has received honoraria for speaking, advisory boards and compensation for congress participation from Sanofi Genzyme, Khondrion, Biogen, UCB, Stealth and Precision Biosciences, outside the submitted work. AB has received honoraria for speaking and participation in advisory boards from Chiesi and Sanofi. He is a member of the European Fabry Registry Board of Advisors (sponsored by Sanofi). IR has received honoraria for speaking and advisory board from Amicus Therapeutics and Sanofi, outside the submitted work. AP has received honoraria for speaking and advisory board from Amicus Therapeutics, Sanofi, Guerbet and Bayer, outside the submitted work. SC has received honoraria for speaking, advisory board and consulting from Amicus Therapeutics, Sanofi and TTLC, outside the submitted work. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}